247 related articles for article (PubMed ID: 36860624)
1. Focal Liver Lesions other than Hepatocellular Carcinoma in Cirrhosis: Diagnostic Challenges.
Möller K; Safai Zadeh E; Görg C; Dong Y; Cui X; Lim A; de Molo C; Serra C; Martín Algíbez A; Berzigotti A; Piscaglia F; Faiss S; Dietrich CF
J Transl Int Med; 2022 Dec; 10(4):308-327. PubMed ID: 36860624
[TBL] [Abstract][Full Text] [Related]
2. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
3. Focal liver lesions in cirrhosis: Role of contrast-enhanced ultrasonography.
Bartolotta TV; Randazzo A; Bruno E; Taibbi A
World J Radiol; 2022 Apr; 14(4):70-81. PubMed ID: 35646291
[TBL] [Abstract][Full Text] [Related]
4. Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study.
de Sio I; Iadevaia MD; Vitale LM; Niosi M; Del Prete A; de Sio C; Romano L; Funaro A; Meucci R; Federico A; Loguercio C; Romano M
United European Gastroenterol J; 2014 Aug; 2(4):279-87. PubMed ID: 25083285
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of focal liver lesions with contrast-enhanced ultrasonography in patients with hepatitis C-induced liver cirrhosis.
Rahbin N; Siösteen AK; Elvin A; Blomqvist L; Hagen K; Hultcrantz R; Aleman S
Acta Radiol; 2008 Apr; 49(3):251-7. PubMed ID: 18365808
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis.
Kim TK; Jang HJ
World J Gastroenterol; 2014 Apr; 20(13):3590-6. PubMed ID: 24707142
[TBL] [Abstract][Full Text] [Related]
9. Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound.
Wong GL; Xu HX; Xie XY
World J Radiol; 2009 Dec; 1(1):25-36. PubMed ID: 21160718
[TBL] [Abstract][Full Text] [Related]
10. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.
D'Onofrio M; Faccioli N; Zamboni G; Malagò R; Caffarri S; Fattovich G; Mucelli RP
Radiol Med; 2008 Oct; 113(7):978-91. PubMed ID: 18779929
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
Kim TK; Lee KH; Khalili K; Jang HJ
Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of regenerative nodule, dysplastic nodule, and small hepatocellular carcinoma in cirrhotic patients: a contrast-enhanced ultrasound-based multivariable model analysis.
Duan Y; Xie X; Li Q; Mercaldo N; Samir AE; Kuang M; Lin M
Eur Radiol; 2020 Sep; 30(9):4741-4751. PubMed ID: 32307563
[TBL] [Abstract][Full Text] [Related]
14. Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound.
Jang HJ; Kim TK; Wilson SR
Eur J Radiol; 2009 Dec; 72(3):418-24. PubMed ID: 18834687
[TBL] [Abstract][Full Text] [Related]
15. Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.
Strobel D; Jung EM; Ziesch M; Praktiknjo M; Link A; Dietrich CF; Klinger C; Schultheiß M; Jesper D; Schellhaas B
Eur Radiol; 2021 Oct; 31(10):7614-7625. PubMed ID: 33855588
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
18. How to detect hepatocellular carcinoma in cirrhosis.
Ward J; Robinson PJ
Eur Radiol; 2002 Sep; 12(9):2258-72. PubMed ID: 12195479
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients.
Wu W; Chen M; Yan K; Dai Y; Yin S; Yang W; Fan Z
Chin J Cancer Res; 2015 Feb; 27(1):83-9. PubMed ID: 25717230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
